Patents by Inventor Bruce Kimmel

Bruce Kimmel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Automated scanning path planner with path calibration for high frame rate multi photon laser scanning microscope with wide field of view
    Patent number: 9939381
    Abstract: The invention relates to multi-photon excitation microscopy, and in particular to a path planning module and calibration module for three mirror adaptive sampling system configured to automatically generate an optimized RGG mirror scanning path by scanning a Field of View, identifying multiple region of interest targets, and analyzing the targets to generate an optimized path. The invention also relates to methods for maintaining a high frame rate during wide field of view sampling.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: April 10, 2018
    Assignee: VIDRIO TECHNOLOGIES, LLC
    Inventors: Bruce Kimmel, Jonathan King, Nathan Clack, Georg Jaindl
  • PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY
    Publication number: 20130316448
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Application
    Filed: August 2, 2013
    Publication date: November 28, 2013
    Applicant: AMGEN INC.
    Inventors: Thomas C. Boone, Kenneth D. Wild, Karen C. Sitney, Ho-Sung Min, Bruce Kimmel
  • Peptides and related molecules that modulate nerve growth factor activity
    Patent number: 8513396
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: August 20, 2013
    Assignee: Amgen Inc.
    Inventors: Thomas C. Boone, Kenneth D. Wild, Karen C. Sitney, Ho-Sung Min, Bruce Kimmel
  • PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY
    Publication number: 20120129771
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Application
    Filed: February 1, 2012
    Publication date: May 24, 2012
    Applicant: AMGEN INC.
    Inventors: Thomas C. Boone, Kenneth C. Wild, Karen C. Sitney, Hosung Min, Bruce Kimmel
  • Peptides and related molecules that modulate nerve growth factor activity
    Patent number: 8124724
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Grant
    Filed: January 24, 2008
    Date of Patent: February 28, 2012
    Assignee: Amgen Inc.
    Inventors: Thomas C. Boone, Kenneth C. Wild, Karen C. Sitney, Hosung Min, Bruce Kimmel
  • Peptides and related molecules that modulate nerve growth factor activity
    Publication number: 20100240582
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Application
    Filed: January 24, 2008
    Publication date: September 23, 2010
    Inventors: Thomas C. Boone, Kenneth D. Wild, Karen C. Sitney, Hosung Min, Bruce Kimmel
  • Non-Natural Amino Acid Polypeptides Having Modified Immunogenicity
    Publication number: 20090093405
    Abstract: Non-naturally encoded amino acid polypeptides with modulated immunogenicity and uses thereof are provided.
    Type: Application
    Filed: January 18, 2007
    Publication date: April 9, 2009
    Applicant: AMBRX, INC.
    Inventors: John W. Wallen, III, Bee-Cheng Sim, Bruce Kimmel, Thomas O. Daniel
  • Peptides and related molecules that modulate nerve growth factor activity
    Patent number: 7371559
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: May 13, 2008
    Assignee: Amgen Inc.
    Inventors: Thomas C. Boone, Kenneth C. Wild, Karen C. Sitney, Hosung Min, Bruce Kimmel
  • Human Interferon Molecules and Their Uses
    Publication number: 20080108792
    Abstract: Modified human interferon polypeptides and uses thereof are provided.
    Type: Application
    Filed: October 26, 2007
    Publication date: May 8, 2008
    Applicant: AMBRX, INC.
    Inventors: Anna-Maria Hays, Bruce Kimmel, Ho Sung Cho, Bee-Cheng SIM, David Litzinger, Roberto Mariani, Vadim Kraynov, Nick Knudsen, Thomas Daniel, Alan Koder, Stuart Bussell, Junjie Liu, Zhenwei Miao, Theresa Morrow
  • NOVEL ANTIGEN-BINDING POLYPEPTIDES AND THEIR USES
    Publication number: 20080085277
    Abstract: Novel antigen-binding polypeptides (ABP) and uses thereof are provided.
    Type: Application
    Filed: October 16, 2007
    Publication date: April 10, 2008
    Applicant: AMBRX, INC.
    Inventors: Ho Sung CHO, Thomas DANIEL, Troy WILSON, Thomas CUJEC, Feng TIAN, Anna-Maria HAYS, Bruce KIMMEL, Lillian HO
  • NOVEL ANTIGEN-BINDING POLYPEPTIDES AND THEIR USES
    Publication number: 20080081038
    Abstract: Novel antigen-binding polypeptides (ABP) and uses thereof are provided.
    Type: Application
    Filed: October 16, 2007
    Publication date: April 3, 2008
    Applicant: AMBRX, INC.
    Inventors: Ho Sung CHO, Thomas DANIEL, Troy WILSON, Thomas CUJEC, Feng TIAN, Anna-Maria HAYS, Bruce KIMMEL, Lillian HO
  • NOVEL ANTIGEN-BINDING POLYPEPTIDES AND THEIR USES
    Publication number: 20080050374
    Abstract: Novel antigen-binding polypeptides (ABP) and uses thereof are provided.
    Type: Application
    Filed: October 16, 2007
    Publication date: February 28, 2008
    Applicant: AMBRX, INC.
    Inventors: Ho Sung CHO, Thomas DANIEL, Troy WILSON, Thomas CUJEC, Feng TIAN, Anna-Maria HAYS, Bruce KIMMEL, Lillian HO
  • Novel antigen-binding polypeptides and their uses
    Publication number: 20060153860
    Abstract: Novel antigen-binding polypeptides (ABP) and uses thereof are provided.
    Type: Application
    Filed: June 17, 2005
    Publication date: July 13, 2006
    Applicant: Ambrx, Inc.
    Inventors: Ho Cho, Thomas Daniel, Troy Wilson, Thomas Cujec, Feng Tian, Anna-Maria Hays, Bruce Kimmel, Lillian Ho
  • Biosynthetic polypeptides utilizing non-naturally encoded amino acids
    Publication number: 20060019347
    Abstract: Modified biosynthetic polypeptide molecules, methods for manufacturing, and uses thereof are provided.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Applicant: Ambrx, Inc.
    Inventors: Ho Cho, Thomas Daniel, Anna-Maria Hays, Troy Wilson, David Litzinger, Roberto Mariani, Bruce Kimmel, William Keefe
  • Peptides and related molecules that modulate nerve growth factor activity
    Publication number: 20050222035
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Application
    Filed: May 11, 2005
    Publication date: October 6, 2005
    Inventors: Thomas Boone, Kenneth Wild, Karen Sitney, Hosung Min, Bruce Kimmel
  • Peptides and related molecules that modulate nerve growth factor activity
    Patent number: 6919426
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Grant
    Filed: September 18, 2003
    Date of Patent: July 19, 2005
    Assignee: Amgen Inc.
    Inventors: Thomas C. Boone, Kenneth C. Wild, Karen C. Sitney, Hosung Min, Bruce Kimmel
  • Peptides and related molecules that modulate nerve growth factor activity
    Publication number: 20040121959
    Abstract: The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided.
    Type: Application
    Filed: September 18, 2003
    Publication date: June 24, 2004
    Inventors: Thomas C. Boone, Kenneth C. Wild, Karen C. Sitney, Hosung Min, Bruce Kimmel